Anthony El-Khoueiry, Md

Los Angeles, California 90033

0 studies enrolling now · 2 studies all time

What they study most

Cancer, Solid Tumors That Overexpress HER2 (HER2 Positive)

Studies at this site

• Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors — Completed
• Phase 1, Multiple Ascending Dose Study of Anti-HER2 FCAB FS102 in HER2 Positive Solid Tumors (Anti HER2 Fcab) — Completed